Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)

v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Revenues $ 4,349 $ 3,564 $ 13,968 $ 10,534
Cost of revenues 2,699 2,294 8,734 6,597
Gross profit 1,650 1,270 5,234 3,937
Operating expenses:        
Research and development 557 427 1,726 1,403
Selling, general and administrative 1,771 1,874 5,618 5,588
Total operating expenses 2,328 2,301 7,344 6,991
Loss from operations (678) (1,031) (2,110) (3,054)
Other (expense) income, net (271) 112 (812) 675
Net loss before income taxes (949) (919) (2,922) (2,379)
Income tax benefit (expense) 130 (9) 328 (302)
Net loss $ (819) $ (928) $ (2,594) $ (2,681)
Net loss per share: basic $ (0.48) $ (0.63) $ (1.56) $ (2.40)
Net loss per share: diluted $ (0.48) $ (0.63) $ (1.56) $ (2.40)
Weighted-average number of shares outstanding: basic 1,713 1,464 1,667 1,117
Weighted-average number of shares outstanding: diluted 1,713 1,464 1,667 1,117
Other comprehensive loss:        
Net loss $ (819) $ (928) $ (2,594) $ (2,681)
Foreign currency translation adjustments 174 (357) 1,185 (1,831)
Comprehensive loss $ (645) $ (1,285) $ (1,409) $ (4,512)